Search results for " market"
Article
Quality by design for biotechnology products—part 1
…ign space, process changes and comparability, comparability protocols and expanded change protocols, marketed products, and a CMC post-approval management plan. It also includes the overall conclusi…
Article
Evaluating the Use of Continuous Chromatography
Taking a closer look
In speaking with BioPharm International®, Christine Rozanas, PhD, global product marketing manager at Cytiva, discussed the advantages and persistent challenges with implementin…
Article
Advances in Sterilization Technologies for Overcoming Viral-Vector Manufacturing Challenges
“For a 50-L bioreactor run, the intermediate downstream processing volumes can already be below 2 L after the capture steps, but single-use mixers currently on the market start at 50 L,” she explains.…
Article
Top Tips for Successful Development of Antibody Chromatography Processes
So you have to understand these different types of resins that are on the market. And together with that, you must have knowledge about the target molecule and how it behaves in what conditions. Is it…
Article
Discovering the unknown: How does in silico process development change PD scientists’ work?
Enhancing quality, capacity, speed and flexibility throughout the process are what makes it difference when developing a biopharmaceutical for successful market entry. By simulating the process to gai…
Article
Top challenges in recombinant protein purification process development
…t but not have any amino acids left after purification, which is quite different from any tag on the market today. And a reason that process developers and drug producers do not use this today is bec…
Article
How can you harness the potential of nucleic acid therapeutics?
At Cytiva, the new team is here to support you. We can help you throughout the
development of your manufacturing workflow for oligonucleotides
and the purification of mRNA drug subs…
Article
The oligonucleotide synthesis process consists of a repetitive four-step cycle
The oligo therapeutics market is growing in promise for treating cancers, genetic diseases, and other conditions. In this animated video you can watch the oligonucleotide synthesis process as …
Article
Simulation gets therapies to patients faster and smarter
Digital solutions are helping to decrease therapeutic time to market but remain challenging – learn how we work on overcoming that challenge!
Read article
Article
The Smart Benefit of Digital Systems in Preclinical Studies
… biopharmaceutical industry strategizes ways to better decrease costs while speeding up timelines to market. Here, a closer look at smart tools highlights how they support enhanced and intelligent da…